Potential of ChatGPT in facilitating research in radiation oncology?

Matthias Gückenberger(University of Zurich), Michael Mayinger(University Hospital of Zurich), Nicolaus Andratschke(University Hospital of Zurich), Astrid Heusel(University of Zurich), Maiwand Ahmadsei(University Hospital of Zurich), Jonas Willmann(University of North Texas), Esmée L. Looman(University of Zurich), Eugenia Vlaskou Badra(University Hospital of Zurich), Jens von der Grün(University of Zurich), Tiuri E. Kroese(University of Zurich), Sabrina Reichl(University of Zurich), Stephanie Tanadini‐Lang(University of Zurich), Sandeep Kamal(University of Zurich), Sebastian M. Christ(University of Zurich)
Radiotherapy and Oncology
September 1, 2023
10.1016/j.radonc.2023.109894
Cited by 14

Related Papers

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
|Annals of Oncology|2021|577
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
|Annals of Oncology|2020|232
Radiographic changes after lung stereotactic ablative radiotherapy (SABR) – Can we distinguish recurrence from fibrosis? A systematic review of the literature
|Radiotherapy and Oncology|2012|230